Article Text

Download PDFPDF

A quality improvement approach to the reduction of HIV-related stigma and discrimination in healthcare settings
  1. Daniel J Ikeda1,
  2. Laura Nyblade2,
  3. Kriengkrai Srithanaviboonchai3,
  4. Bruce D Agins1,4
  1. 1HEALTHQUAL, Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, USA
  2. 2Research Triangle Institute, Washington, District of Columbia, USA
  3. 3Dept of Community Medicine, Faculty of Medicine, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand
  4. 4Department of Epidemiology and BIostatistics, University of California San Francisco, San Francisco, California, USA
  1. Correspondence to Dr Bruce D Agins; bruce.agins{at}ucsf.edu
  • Present affiliation The present affiliation of Daniel J Ikeda is: Harvard School of Medicine, MA, Boston, United States

Abstract

HIV-related stigma and discrimination (S&D) in healthcare settings represents a potent barrier to achieving global aims to end the HIV epidemic, particularly in Southeast Asia (Cambodia, Lao People’s Democratic Republic, Thailand and Vietnam). Evidence-based approaches for measuring and reducing S&D in healthcare settings exist, but their incorporation into routine practice remains limited, in part due to a lack of attention to how unique organisational practices—beyond the knowledge and attitudes of individuals—may abet and reinforce S&D. Application of a quality improvement (QI) approach in which facilities leverage routine measurement of S&D among healthcare workers and people living with HIV, team-based learning, root cause analysis, and tests of change offers a novel means through which to address S&D in local contexts and develop interventions to address individual-level and organisation-level drivers of S&D. To support the adoption of a QI approach to S&D reduction, the Southeast Asia Stigma Reduction QI Learning Network was launched with Ministries of Health from Cambodia, Lao PDR, Thailand and Vietnam, to co-develop strategies for implementing QI activities in participating facilities. Since the inception of Network activities in 2017, Ministry-led QI activities to address S&D have been implemented in 83 facilities and 29 provinces across participating countries. Moreover, 27 strategies and interventions have been tested to date and are being evaluated for scale up by participating facilities, spanning multiple drivers and organisational domains. Lessons learned through Network activities offer national-level and facility-level HIV programmes best practices for implementing a QI approach to S&D reduction.

  • HIV
  • stigma
  • discrimination
  • quality improvement

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Handling editor Seye Abimbola

  • Contributors DJI and BDA conceived the initial idea for the manuscript. DJI and BDA wrote the first draft. All authors provided critical feedback and approved the final submission.

  • Funding This work was supported by the US President’s Emergency Plan for AIDS Relief as part of the Health Resources and Services Administration’s Quality Improvement Capacity for Impact Project award #U1NHA08599. Its contents do not necessarily reflect the views of the US Government. Publication made possible in part by support from the UCSF Open Access Publishing Fund.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement No additional data are available.